Diagnostic tools in Sepsis
Recent research has identified new molecules that are informative and help clinicians understand the etiology of the patient’s clinical symptoms, paving the way for personalized medicine in the field of sepsis.
Diagnostic tools in COVID-19
The global COVID-19 pandemic has challenged health systems world-wide, with about 5% of patients requiring admission to intensive care units. Read more on the relevance of SphingoTec’s novel and established biomarker assays in the management of critically ill COVID-19 patients.